Phenolic-derived compounds in osteoporosis—Mechanisms, clinical evidence, and drug delivery: A review

Haryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid · 2026

Read Phenolic-derived compounds in osteoporosis—Mechanisms, clinical evidence, and drug delivery: A review by Haryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13130750.txt.

Description

Haryati Ahmad Hairi and colleagues reviewed plant phenolic compounds as a possible aid against osteoporosis. Osteoporosis thins bone and weakens its structure, raising fracture risk. It develops when bone removal outruns bone building, driven by oxidative stress, long-term inflammation, cell-death pathways, and hormone change, especially loss of estrogen.

Sections explain those disease mechanisms first, with stress and hormone problems given special weight. Evidence on phenolic compounds follows, including recent clinical observations and delivery methods meant to make the compounds work better. The authors judge these plant-based compounds promising for preventing and managing weak bones, while presenting them as a strategy still being developed.

Catalog record

CREATORHaryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE84 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13130750

Browse the full library · About the Tower of Babel